InvestorsHub Logo
Followers 1
Posts 288
Boards Moderated 0
Alias Born 06/23/2013

Re: XenaLives post# 192077

Thursday, 05/09/2019 12:39:40 AM

Thursday, May 09, 2019 12:39:40 AM

Post# of 462045
Did the Australians take on the Parkinson’s dementia trial in order to demonstrate efficacy in kangaroo poachers? Will having Data from the local population enable them to move quickly on approval subject to phase for testing? Does that mean we could have approval have leased in Australia this year for Parkinson’s dementia? And one final question for any of you posters down under, does the Australian public health service permit off label prescribing? Do they have a process for that? Or do they allow individual positions with in the service prescribe off label? Another words once the Aussies jump to phase 4, will the PHS Val prescribing for a LZ as well as Parkinson’s dementia?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News